CADTH has received notice of a pending submission from Pierre Fabre for propanolol (Hemangiol) for infantile haemangioma. For information about the patient input process or for additional instructions, please see the Patient Input page of the CADTH website. Note that only patient groups may submit input.

For more details, go to: http://www.cadth.ca/en/products/cdr/patient-group-input-form/393